NOVO Nordisk

Disclaimer

MEDOC26 is the 12th edition of The Middle-East Endocrine, Diabetes & Obesity Congress, organized by The Saudi Scientific Diabetes Society. The conference aims to provide a platform for researchers, clinicians, policy makers, and industry representatives to share the latest advances and challenges in the prevention, diagnosis, and treatment of obesity and diabetes.

Novo Nordisk

MIDDLE EAST ENDOCRINE, DIABETES & OBESITY CONGRESS

Pages

Disclaimer